Our mission is to bring expertise and partnerships to our surgeon and hospital customers. Please let us know if you would like to discuss any of the systems you find here.
Matt Coakley, Managing Partner: email@example.com
Josh Mikulich, Managing Partner: firstname.lastname@example.org
EIT Acquired by J&J, September 2018
EIT can now be found in the spine portfolio of Depuy Synthes, a Johnson & Johnson company. Congrats to the entire EIT team and Ortho Sales Partners!
Emerging Implant Technologies’ EIT Cellular Titanium (w/o graft window) – greater primary stability, less subsidence, similar fusion results to PEEK with autograft
Here are six things to know. 1. EIT is a German medical device manufacturer focused on creating spinal implants with additive manufacturing. 2. The company’s implants are made of 3D-printed EIT Cellular Titanium with a porosity of 80 percent. 3. The EFFECT trial is a prospective controlled trial evaluating the radiological results of 50
EIT Emerging Implant Technologies Acquires 22 Patents for 3D Printed Expandable Cage Technology Based on Living Hinges from Dr. Morgan Lorio
Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal applications by utilizing additive manufacturing (“3D-Printing”), today announced the acquisition of a full patent portfolio of 22 issued and pending patents for 3D printed expandable spinal fusion cages based on living hinges from Morgan P. Lorio, MD.